
Company valuation, historical trends, and peer comparisons.
According to Bavarian Nordic A/S’s latest financial reports and current stock price. The company's current Enterprise Value is 18.11B. This represents a change of 26.67% compared to the average of 14.30B of the last 4 quarters.
The mean historical Enterprise Value of Bavarian Nordic A/S over the last ten years is 11.50B. The current 18.11B Enterprise Value has changed 57.52% with respect to the historical average. Over the past ten years (40 quarters), BVNRY's Enterprise Value was at its highest in in the September 2021 quarter at 20.98B. The Enterprise Value was at its lowest in in the March 2020 quarter at 3.47B.
Average
11.50B
Median
11.29B
Minimum
5.81B
Maximum
17.50B
Discovering the peaks and valleys of Bavarian Nordic A/S Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 70.08%
Maximum Annual Enterprise Value = 17.50B
Minimum Annual Increase = -36.10%
Minimum Annual Enterprise Value = 5.81B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 13.31B | 0.11% |
| 2024 | 13.29B | 8.25% |
| 2023 | 12.28B | -24.25% |
| 2022 | 16.21B | -7.38% |
| 2021 | 17.50B | 70.08% |
| 2020 | 10.29B | 20.64% |
| 2019 | 8.53B | 46.91% |
| 2018 | 5.81B | -36.10% |
| 2017 | 9.09B | 5.05% |
| 2016 | 8.65B | -29.22% |
The current Enterprise Value of Bavarian Nordic A/S (BVNRY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
12.96B
5-year avg
14.52B
10-year avg
11.50B
Bavarian Nordic A/S’s Enterprise Value is greater than Valneva SE (568.89M), greater than Novavax, Inc. (1.86B), greater than Vir Biotechnology, Inc. (1.85B), greater than Vaxart, Inc. (54.01M), greater than Vaxcyte, Inc. (8.07B), less than Moderna, Inc. (102.72B), greater than BioNTech SE (10.13B), greater than Arcturus Therapeutics Holdings Inc. (140.41M), greater than Oragenics, Inc. (-2185736.00), greater than CEL-SCI Corporation (25.64M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 568.89M | $517.10M | |
| 1.86B | $1.76B | |
| 1.85B | $1.99B | |
| 54.01M | $97.13M | |
| 8.07B | $10.34B | |
| 102.72B | $103.15B | |
| 10.13B | $22.10B | |
| 140.41M | $308.96M | |
| -2185736.00 | $1.68M | |
| 25.64M | $24.27M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bavarian Nordic A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bavarian Nordic A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Bavarian Nordic A/S's Enterprise Value?
What is the highest Enterprise Value for Bavarian Nordic A/S (BVNRY)?
What is the 3-year average Enterprise Value for Bavarian Nordic A/S (BVNRY)?
What is the 5-year average Enterprise Value for Bavarian Nordic A/S (BVNRY)?
How does the current Enterprise Value for Bavarian Nordic A/S (BVNRY) compare to its historical average?